NCT06040970 2025-12-02Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial CancerIcahn School of Medicine at Mount SinaiPhase 1/2 Recruiting54 enrolled
NCT05949632 2025-08-03A Study of INCB099280 in Combination With Axitinib in Adults With Advanced Solid TumorsIncyte CorporationPhase 1/2 Terminated5 enrolled
NCT05559879 2025-05-04Cabozantinib and Dostarlimab in Recurrent Gynecologic CarcinosarcomaUniversity of Alabama at BirminghamPhase 1/2 Recruiting37 enrolled
NCT03476681 2025-04-24Study of NEO-201 in Solid Tumors Expansion CohortsPrecision Biologics, IncPhase 1/2 Recruiting121 enrolled